Attention: open in a new window. E-mailPrintPDF
GPW-listed biotech firm OncoArendi Therapeutics assures it is close to signing substantial deals for the commercialisation of pharmaceuticals. CEO and major shareholder Marcin Szumowski says he hopes that he will…

Order subscription to read this article




Order at
Order from our partners:

Call us:

Find us: